Aditya Birla Sun Life Pharma & Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • (-1.24%)Nav, as on 15-01-2021

  • Previous Nav

  • Net Change on 15-01-2021

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P BSE Health Care - TRI 4.24 12.18 60.96 14.65 7.76 15.05

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 69.14 21.79 13.17 2.02 4,383.33
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 67.19 16.99 9.97 2.80 649.26
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 64.64 19.34 9.39 2.63 419.33

Fund Holdings as on 31-December-2020

  • Dr. Reddys Laboratories Limited

  • Sun Pharmaceutical Industries Limited

  • Cipla Limited

  • Divi's Laboratories Limited

  • Lupin Limited

  • Aurobindo Pharma Limited

  • Apollo Hospitals Enterprise Limited

  • Torrent Pharmaceuticals Limited

  • Biocon Limited

  • Zydus Wellness Limited

  • IPCA Laboratories Limited

  • Cadila Healthcare Limited

  • METROPOLIS HEALTHCARE LIMITED

  • Fortis Healthcare Limited

  • Atul Limited

  • Alkem Laboratories Limited

  • Sanofi India Limited

  • Clearing Corporation of India Limited

  • Pfizer Limited

  • Strides Pharma Science Limited

  • Abbott India Limited

  • Indoco Remedies Limited

  • Eris Lifesciences Limited

  • Gland Pharma Limited

  • Ajanta Pharmaceuticals Limited

  • Net Receivables / (Payables)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Consumer Food

  • Chemicals

  • Miscellaneous

View More

  • Cash

  • Equity

View More

About Aditya Birla Sun Life Pharma & Healthcare Fund

Scheme Analysis

Aditya Birla Sun Life Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Aditya Birla Sun Life Mutual Fund. It was launched on 10-Jul-2019 and currently has an AUM of ₹459.12 crore. Aditya Birla Sun Life Pharma & Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P BSE Health Care - TRI as secondary index.

The NAV of Aditya Birla Sun Life Pharma & Healthcare Fund ended down ₹-0.21(-1.24%)yesterday to ₹16.71.

Among its top 3 holdings the fund has exposure to Dr. Reddys Laboratories Limited, and

The Aditya Birla Sun Life Pharma & Healthcare Fund is managed by Dhaval Shah .

Fund House Contact

One India Bulls Centre , Tower 1, 17th Floor, Jupiter Mill Compound, 841, Senapati Bapat Marg, Elphinstone Road, Mumbai - 400 013

022-43568000
022-43568110/ 8111